Skip to Content
Merck

Islet adaptation to obesity and insulin resistance in WNIN/GR-Ob rats.

Islets (2015-04-04)
Himadri Singh, Sireesha Ganneru, Venkata Malakapalli, Maniprabha Chalasani, Giridharan Nappanveettil, Ramesh R Bhonde, Vijayalakshmi Venkatesan
ABSTRACT

WNIN/GR-Ob mutant rat is a novel animal model to study metabolic syndrome (obesity, insulin resistance, hyperinsulinemia, impaired glucose tolerance and cardiovascular diseases). We have investigated the islet characteristics of obese mutants at different age groups (1, 6 and 12 months) to assess the islet changes in response to early and chronic metabolic stress. Our data demonstrates altered islet cell morphology and function (hypertrophy, fibrotic lesions, vacuolation, decreased stimulation index, increased TNFα, ROS and TBARS levels) in mutants as compared to controls. Furthermore, network analysis (gene-gene interaction) studied in pancreas demonstrated increased inflammation as a key factor underlying obesity/metabolic syndrome in mutants. These observations pave way to explore this model to understand islet adaptation in response to metabolic syndrome.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
Monoclonal Anti-Insulin antibody produced in mouse, clone K36AC10, ascites fluid